พบ "Public health policy"ทั้งหมด 1,196 ผลลัพธ์
Funding cuts imperil European fight against TB, HIV
(Reuters) – Cuts in global funding for Eastern Europe and Central Asia are undermining the fight against tuberculosis (TB) and the AIDS virus, threatening to push already high rates of disease and drug-resistance even higher, experts said on Wednesday.In a report by leading European non-governmental
Full Report: A cost-utility analysis of policy options for dietary sodium intake control in Thailand
Background: Excessive intake of sodium is associated with elevated blood pressure, a risk factor that contributes to non-communicable diseases such as hypertension, chronic kidney disease, cardiovascular diseases, and stomach cancer. Interventions and policies to control population-wide salt intake
Free Drugs List (FDL) Nepal
Governments worldwide are facing the challenge of balancing limited resources and the increasing need for improving the healthcare of their population. Universal Healthcare Coverage (UHC) to ensure equitable access to essential health services doubles the challenge for governments, especially in resource-limited settings. As a result, health priori
Framework to guide the use of mathematical modelling in evidence-based policy decision-making
Abstract
Introduction The COVID-19 pandemic highlighted the significance of mathematical modelling in decision-making and the limited capacity in many low-income and middle-income countries (LMICs). Thus, we studied how modelling supported policy decision-making processes in LMICs during the pand
Foreword: Health Economic Evaluations in Low- and Middle-income Countries: Methodological Issues and Challenges for Priority Setting
CATHERINE PITTa,*
ANNA VASSALLa,
YOT TEERAWATTANANONb,
ULLA K. GRIFFITHSa,
LORNA GUINNESSa,
AMIAN WALKERc,
NICOLA FOSTERd and KARA HANSONa
a Department of Global Health & Development, London School of Hygiene & Tropical Medicine, London, UK
b Health Intervention and Technology Assess
For Big Drug Companies, a Headache Looms
WASHINGTON — It would seem a business executive’s dream: legally pay a competitor to keep its product off the market for years.Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it.Until th
Footer
©
Copyright - HITAP
All Rights Reserved.
มูลนิธิเพื่อการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ
สำนักงานใหญ่ : 88/22 หมู่ที่ 4 อาคาร 6 ชั้น 6 กรมอนามัย กระทรวงสาธารณสุขถนนติวานนท์ ตำบลตลาดขวัญ อำเภอเมืองนนทบุรี จังหวัดนนทบุรี 11000
10 / หน้า